Login / Signup

Dual therapy with oral anticoagulation and single antiplatelet agent versus monotherapy with oral anticoagulation alone in patients with atrial fibrillation and stable ischemic heart disease: a systematic review and meta-analysis.

Aamina ShakirArsalan KhanSiddharth AgarwalShari CliftonJessica ReeseMuhammad Bilal MunirUsama Bin NasirSafi U KhanRakesh GopinathannairChristopher V DeSimoneAbhishek DeshmukhWarren M JackmanStavros StavrakisZain Ul Abideen Asad
Published in: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing (2022)
In patients with AF and stable ischemic heart disease, OAC + SAPT as compared to OAC monotherapy is associated with a significant increase in bleeding events without a significant reduction in thrombotic events, cardiovascular mortality, and all-cause mortality.
Keyphrases
  • atrial fibrillation
  • combination therapy
  • venous thromboembolism
  • open label
  • cardiovascular events
  • stem cells
  • clinical trial